Full Length Research Paper
References
|
Ballard MS, Schønheyder HC, Knudsen JD (2016). The changing epidemiology of group B streptococcus bloodstream infection: A multi-national population-based assessment. Infectious Diseases (Lond) 48(5):386-391. |
|
|
Baron EJ, Miller JM, Weinstein MP (2013). A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infections Disease: 2013 Recommendations by the Infections Disease Society of America (IDSA) and the American Society for Microbiology (ASM). Clinical Infectious Diseases 33(24):3020-3021. |
|
|
Bhatia BD, Basu S (2007). Newer diagnostic tests for bacterial disease. Indian Journal of Pediatrics 74(7):673- 677. |
|
|
Bloos F, Marshall JC, Dellinger RP (2011). Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: A multicenter observational study. Critical Care 15(2):88. |
|
|
Buetti N, Marschall J, Atkinson A (2015). National Bloodstream Infection Surveillance in Switzerland 2008-2014: Different Patterns and Trends for University and Community Hospitals. Arquivos Brasileiros De Oftalmologia 37(9):1060-1067. |
|
|
Bursle EC, Dyer J, Looke DF (2015). Risk factors for urinary catheter associated bloodstream infection. Journal of Infection 70(6):585-591. |
|
|
Charchaflieh J, Rushbrook J, Worah S (2015). Activated Complement Factors as Disease Markers for Sepsis. Disease Markers 2015:382-463. |
|
|
Clec'h C, Fosse JP, Karoubi P (2006). Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Critical Care Medicine 34:102-107. |
|
|
David MZ, Daum RS, Bayer AS (2014). Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. Clinical Infectious Diseases 59:798-807. |
|
|
Dellinger RP, Carlet JM, Masur H (2004). Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock Critical. Intensive Care Medicine 32(3):858-873. |
|
|
Dellinger RP, Levy MM, Carlet JM (2008). Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Medicine 34(1):17-60. |
|
|
Esposito AL, Gleckman RA, Cram S, Crowley M, McCabe F (1980). Community‑acquired bacteremia in the elderly: Analysis of one hundred consecutive episodes. Journal of the American Geriatrics Society 28:315‑319. |
|
|
Garrouste OM, Chevret S, Arlet G (1997). Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients: A prospective study based on genomic DNA analysis. American Journal of Respiratory and Critical Care 156:1647-1655. |
|
|
Gaur AH, Miller MR, Gao C (2013). Evaluating application of the National Healthcare Safety Network central line-associated bloodstream infection surveillance definition: A survey of pediatric intensive care and hematology/oncology units. Infection Control and Hospital Epidemiology 34(7):663-670. |
|
|
Giamarellos EJ, Tsangaris I, Kanni T (2011). Procalcitonin as an early indicator of outcome in sepsis: A prospective observational study. Journal of Hospital Infection 77(1):58-63. |
|
|
Gibot S, Cravoisy A (2004). Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clinical Medicine and Research 2(3):181-187. |
|
|
Godfroid J, Cloeckaert A, Liautard JP (2005). From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Veterinary Research 36(3):313-326. |
|
|
Goto M, Al-Hasan MN (2013). Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clinical Microbiology and Infection 19:501-509. |
|
|
Jesús RB, Marina C, Retamar P (2010). Current management of bloodstream infections. Expert Review of Anti-Infective Therapy 8(7):815-829. |
|
|
Laupland KB (2013). Incidence of bloodstream infection: A review of population-based studies. Clinical Microbiology and Infection 19:492-500. |
|
|
Laupland KB, Niven DJ, Pasquill K (2018). Culturing rate and the surveillance of bloodstream infections: A population-based assessment. Clinical Microbiology and Infection 24(8). |
|
|
Lee SW, Hong Ys, Park DW (2008). Lactic acidisis not hyperlactatemia as a predicyor of in-hospital mortality in sepsis emergency patients. Emergency Medicine Journal 25(10):659-665. |
|
|
Levy MM, Fink MP, Marshall JC (2003). 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Medicine 29(4):530-538. |
|
|
Mehl A, Åsvold BO, Lydersen S (2017). Burden of bloodstream infection in an area of Mid-Norway 2002-2013: A prospective population-based observational study. BMC Infectious Diseases 17(1):205. |
|
|
Müller B, Becker KL, Schächinger H (2000). Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Critical Care Medicine 28(4):977-983. |
|
|
Murrary PR (2003). Manual of clinical microbiology. 8th ed. Washington: ASM 234-246． |
|
|
Napolioni V, MacMurray J (2016). Infectious diseases, IL6 -174G>C polymorphism, and human development. Brain Behavior and Immunity 51:196-203. |
|
|
Otero RM, Nguyen HB, Huang DT (2006). Early goal-directed therapy in severe sepsis and septic shock revisited: Concepts, controversies, and contemporary findings. Chest 130(5):1579-1595. |
|
|
P'ovoa P (2002). C-reactive protein: A valuable marker of sepsis. Intensive Care Medicine 28(3):235-243. |
|
|
Pien BC, Sundaram P, Raoof N (2010). The clinical and prognostic importance of positive blood cultures in adults. The American Journal of Medicine 123:819-828. |
|
|
Povoa P, Almeida E, Moreira P (1998). C-reactive protein as an indicator of sepsis. Intensive Care Medicine 24:1052-1056. |
|
|
Riedl S, Carroll KC (2010). Blood culture: key elements for best practices and future directions. Journal of Infection and Chemotherapy 16(5):301-316. |
|
|
Rodelo JR, Rosa GDL, Valencia ML (2012). D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. American Journal of Emergency Medicine 30(9):1991-1999. |
|
|
Singer M, Reutschman CS, Seymour CW (2016). The Third International Consensus Definitions for Septic Shoch (Sepsis-3.0). Journal of the American Medical Association 315(8):801-810. |
|
|
Skogberg K, Lyytikainen O, Ollgren J (2012). Population-based burden of bloodstream infections in Finland. Clinical Microbiology and Infection 18:170-176. |
|
|
Su LX, Feng L, Song Q (2013). Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction. Mediators of Inflammation 2013:969-875. |
|
|
Sugiyama M, Atomi Y (1997). Treatment of acute cholangitis due to choledocholithiasisin elderly and younger patient. Archives of Surgery 132(10):1129. |
|
|
Wilson J, Elgohari S, Livermore DM (2011). Trends among pathogens reported as causing bacteraemia in England 2004-2008. Clinical Microbiology and Infection 17:451-458. |
|
|
Yan HP, Lu XL, Qiu J (2016). Value of blood lactic acid in evaluating disease severity and prognosis in children with sepsis. Zhongguo Dang Dai Er Ke Za Zhi 18(6):506-510. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
